Kaiser Permanente's highly successful integrated healthcare delivery model has been a tough act for other healthcare systems to follow, and new research suggests their nurses might be the key.
Kaiser Permanente's highly successful integrated healthcare delivery model has been a tough act for other healthcare systems to follow. Now, new research from the University of Pennsylvania suggests that Kaiser's focus on nurses as an important part of care delivery might be the key.
In their study published online in Health Care Management Review, the authors evaluated data from 2006 to 2007 for 564 acute-care hospitals in 4 states to examine whether patient (mortality and failure-to-rescue) and nurse (burnout, job satisfaction, and intent-to-leave) outcomes in Kaiser hospitals were better than in non-Kaiser hospitals, and whether the differences in nursing could help explain patient clinical outcomes. They also compared Kaiser outcomes with Magnet hospitals known to have better nursing work environments.
The authors conclude that differences in nursing explained a significant proportion of the Kaiser outcomes advantage.
Read the associated press release at newswise
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More